Moors & Cabot, Inc. Astrazeneca PLC Call Options Transaction History
Moors & Cabot, Inc.
- $2.05 Billion
- Q2 2025
Call Options
1 transactions
Others Institutions Holding AZN
# of Institutions
1,412Shares Held
496MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.46 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.54 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.95 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.7 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.68 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $266B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...